来自患有异常帕金森病的个体的iPSC-多巴胺神经元中的生物能量和蛋白质加工失衡
Kelsey Bernard1, Mandi J Corenblum1, Paola Tonino2
1Department of Neurology, University of Arizona, Tucson, AZ, United States of America.
Neurobiology of disease
|December 14, 2025
概括
来自患者的干细胞揭示了帕金森病 (PD) 多巴胺神经元已经损害了能量生产和α-synuclein问题. 在诱导多能干细胞衍生多巴胺神经元 (iPSC-DANs) 中的这些发现为PD病理学提供了洞察力.
科学领域:
- 神经科学是一个神经科学.
- 干细胞生物学 干细胞生物学
- 生物化学 生化学
背景情况:
- 帕金森病 (PD) 是一种神经退行性疾病,在大多数情况下具有特异性原因.
- 来自患者的诱导多能干细胞 (iPSC) 为研究PD提供了有价值的人类模型.
- 多巴胺神经元 (DA神经元) 在PD中受到严重影响.
研究的目的:
- 研究来自PD患者的iPSC衍生的DA神经元中的生物能量通路和细胞质量控制.
- 分析能量新陈代谢,线粒体功能和异常性PD中的α-synuclein病理学.
主要方法:
- 差异化的iPSC-DAN线条来自患有特异性PD的个体.
- 使用氧气消耗率 (OCR) 和细胞外酸化率 (ECAR) 分析了氧化酸化 (OXPHOS) 和糖解.
- 使用免疫电子显微镜检查了线粒体动力学,线粒体衰变,α-synuclein聚合和细胞活力.
主要成果:
- PD iPSC-DANs显示了OXPHOS和糖分的受损,对糖分的依赖性增加.
- 观察到肌酸激酶B错位于线粒体,增强了线粒体裂变,破坏了线粒体和氧化应激.
- 在PD神经元中发现单质,化和聚合的α-synuclein增加,与线粒体和自囊相关,导致活力降低.
结论:
- 来自异常性PD患者的人类iPSC-DANs表现出广泛的生物能量缺陷和质量控制机制的损害.
- 这些细胞功能障碍,包括α-synuclein病理和线粒体异常,有助于PD的神经元退化.
- 来自iPSC的模型对于理解帕金森病的复杂病因至关重要.
相关概念视频
Parkinson's Disease: Overview
1.7K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.7K
EPS and iPS Cells in Disease Research
3.3K
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
3.3K
Parkinson's Disease: Treatment
940
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
940
Neural Regulation
43.0K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
43.0K
iPS Cell Differentiation
3.0K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
3.0K
Lysosomal Hydrolases
4.4K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
4.4K


